The current P/E ratio for Merit Medical Systems stock as of Jun 22, 2026 is 28.3. This is calculated based on the current EPS of $2.35 and the stock price of $66.5 per share. The PE ratio has decreased by 28% from the past four quarters average of 39.4.
The average historical PE ratio of Merit Medical Systems for the last ten years is 87.42. The current price-to-earnings ratio of 28.3 is 68% less than the historical average. In the past ten years, MMSI's PE ratio reached its highest point in the Mar 2021 quarter at 665.33, when the stock price was $59.88 and the EPS was $0.09. The lowest point was recorded in the Mar 2026 quarter, when it reached 29.33 with a price of $68.93 and an EPS of $2.35.
Maximum annual increase: 347.53% in 2019
Maximum annual decrease: -37.31% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 40.62 | -13.06% | $88.14 | $2.17 |
| 2024 | 46.72 | 0.86% | $96.72 | $2.07 |
| 2023 | 46.32 | -14.08% | $75.96 | $1.64 |
| 2022 | 53.91 | -25.58% | $70.62 | $1.31 |
| 2021 | 72.44 | N/A | $62.3 | $0.86 |
| 2020 | N/A | N/A | $55.51 | -$0.18 |
| 2019 | 312.2 | 347.53% | $31.22 | $0.1 |
| 2018 | 69.76 | -9.57% | $55.81 | $0.8 |
| 2017 | 77.14 | 30.99% | $43.2 | $0.56 |
| 2016 | 58.89 | 71.04% | $26.5 | $0.45 |
| 2015 | 34.43 | 5.29% | $18.59 | $0.54 |
| 2014 | 32.7 | -18.98% | $17.33 | $0.53 |
| 2013 | 40.36 | 36.49% | $15.74 | $0.39 |
| 2012 | 29.57 | 30.38% | $13.9 | $0.47 |
| 2011 | 22.68 | -37.31% | $13.38 | $0.59 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 29.33 | -27.79% | $68.93 | $2.35 |
| Dec 2025 | 40.62 | -1.91% | $88.14 | $2.17 |
| Sep 2025 | 41.41 | -10.08% | $83.23 | $2.01 |
| Jun 2025 | 46.05 | -8.96% | $93.48 | $2.03 |
| Mar 2025 | 50.58 | 8.26% | $105.71 | $2.09 |
| Dec 2024 | 46.72 | -2.14% | $96.72 | $2.07 |
| Sep 2024 | 47.74 | 12.75% | $98.83 | $2.07 |
| Jun 2024 | 42.34 | -1.07% | $85.95 | $2.03 |
| Mar 2024 | 42.8 | -7.6% | $75.75 | $1.77 |
| Dec 2023 | 46.32 | 16.76% | $75.96 | $1.64 |
| Sep 2023 | 39.67 | -26.02% | $69.02 | $1.74 |
| Jun 2023 | 53.62 | 7.3% | $83.64 | $1.56 |
| Mar 2023 | 49.97 | -7.31% | $73.95 | $1.48 |
| Dec 2022 | 53.91 | 3.99% | $70.62 | $1.31 |
| Sep 2022 | 51.84 | -1.61% | $56.51 | $1.09 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
MMSI's current P/E ratio is lower than the 3, 5 and 10-year averages.
With a P/E of 28.3, MMSI stands above the Healthcare sector average but below the industry and its peers average. Looking at its Healthcare sector average of 24.1, Merit Medical Systems's P/E is 17% higher.
MMSI's PE ratio is less than its peer stocks EW and ICUI, but it is above JNJ's and MDT's. Merit Medical Systems's current PE ratio of 28.3 is less than the average of its peers, which is 36.85.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 18.71 | $67B |
| MDT Medtronic plc | 21.38 | $102.63B |
| JNJ Johnson & Johnson | 27.05 | $568.48B |
| MMSI Merit Medical Systems Inc | 28.8 | $4.04B |
| EW Edwards Lifesciences Corp | 45.96 | $50.01B |
| ICUI Icu Medical Inc | 73.12 | $3.42B |
| ANGO Angiodynamics Inc | N/A | $519.38M |
| TFX Teleflex Inc | N/A | $5.43B |
The price to earnings ratio for MMSI stock as of Jun 22, 2026, stands at 28.3.
As an average over the last 3 years, MMSI stock has a PE ratio of 43.93.
As an average over the last 5 years, MMSI stock has a PE ratio of 55.14.
Over the last ten years, the quarterly PE ratio reached a historic high of 665.33 in the Mar 2021 quarter.
The current price to earnings ratio of MMSI is 68% lower than the 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Merit Medical Systems's stock price is $66.5. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.35. Therefore, Merit Medical Systems's price to earnings ratio for today is 28.3. PE RATIO(28.3) = STOCK PRICE($66.5) / TTM EPS($2.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.